Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ALPMF
Recent news which mentions ALPMF
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
August 05, 2024
Tickers
ALPMF
ALPMY
AZN
MRK
Tags
Briefs
PFE
Stories That Matter
From
Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
May 17, 2024
Tickers
ALPMF
BAYRY
BAYZF
DARE
Tags
DARE
BAYRY
Market News
From
Benzinga
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
October 05, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
General
MRK
Market News
From
Benzinga
Why Is Seagen Stock Trading Higher Today?
September 22, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
Market News
SGEN
why it's moving
From
Benzinga
What's Going On With Neurology Focused Taysha Gene Therapies Stock Today?
September 20, 2023
Tickers
ALPMF
ALPMY
TSHA
Tags
FDA
Small Cap
General
From
Benzinga
Why Shares of Adaptive Biotechnologies Jumped This Week
June 16, 2023
Tickers
ADPT
ALPMF
Tags
ADPT
Recent Press Releases
ALPMF
From
Motley Fool
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
June 08, 2023
Tickers
ALPMF
ALPMY
Tags
News
Briefs
gene therapy
From
Benzinga
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
May 30, 2023
Tickers
ALPMF
ISEE
OKYO
VTRS
Tags
OKYO Pharma
ALPMF
Benzinga
From
Benzinga
Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today's Top Stories
May 15, 2023
Tickers
AAPL
ALPMF
ALPMY
BTI
Tags
ALPMF
Biotech
Benzinga
From
Benzinga
Astellas' Menopause Drug Sores FDA Approval, After Regulatory Setback
May 15, 2023
Tickers
ALPMF
ALPMY
Tags
Health Care
Benzinga
ALPMY
From
Benzinga
Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
May 01, 2023
Tickers
ALPMF
ALPMY
PFE
Tags
Market News
General
Benzinga
From
Benzinga
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'
May 01, 2023
Tickers
ALPMF
ALPMY
ISEE
Tags
Market News
M&A
why it's moving
From
Benzinga
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
April 04, 2023
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
Large Cap
Briefs
News
From
Benzinga
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
March 28, 2023
Tickers
ABBV
ALPMF
BMY
CTMX
Tags
General
Briefs
CTMX
From
Benzinga
Japanese Government Urges China To Release Astellas Pharma's Employee
March 27, 2023
Tickers
ALPMF
ALPMY
Tags
Markets
Market News
News
From
Benzinga
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
March 17, 2023
Tickers
ALPMF
ALPMY
PFE
Tags
Benzinga
Health Care
ALPMF
From
Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
January 31, 2023
Tickers
ALPMF
ALPMY
HZNP
SELB
Tags
General
Briefs
Price Target
From
Benzinga
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
January 24, 2023
Tickers
ALPMF
ALPMY
GSK
NVS
Tags
General
Briefs
ALPMF
From
Benzinga
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs
October 25, 2022
Tickers
ALPMF
ALPMY
TSHA
Tags
General
Briefs
Benzinga
From
Benzinga
Astellas' Menopause Drug Under FDA Review
August 18, 2022
Tickers
ALPMF
ALPMY
Tags
General
FDA
Market News
From
Benzinga
Seagen's Bladder Cancer Trial Data Meets Expectation, Analysts Say
July 26, 2022
Tickers
ALPMF
SGEN
Tags
Health Care
Trading Ideas
Analyst Ratings
From
Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
July 26, 2022
Tickers
ABBV
ALPMF
ANGN
BIIB
Tags
HTGC
News
OWLT
From
Benzinga
Seagen Shares Jump On Positive Data From Urothelial Cancer Trial
July 26, 2022
Tickers
ALPMF
ALPMY
MRK
SGEN
Tags
Benzinga
Biotech
Movers
From
Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
June 28, 2022
Tickers
ALPMF
CNTG
ELYM
EPIX
Tags
STRO
Movers
ROIV
From
Benzinga
Sutro Biopharma Stock Surges On Cancer Treatment Pact
June 28, 2022
Tickers
ALPMF
ALPMY
STRO
Tags
Benzinga
ALPMF
Movers
From
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
Market News
MRK
IPSEY
From
Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
June 27, 2022
Tickers
ALPMF
ALPMY
Tags
Market News
FDA
General
From
Benzinga
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
May 09, 2022
Tickers
ALPMF
ALPMY
TWST
Tags
ALPMY
Health Care
Trading Ideas
From
Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
April 13, 2022
Tickers
ALPMF
ALPMY
SGEN
Tags
Benzinga
Health Care
ALPMF
From
Benzinga
Astellas' Menopause Drug Suffers Setback After Failed Asian Trial
March 15, 2022
Tickers
ALPMF
ALPMY
Tags
Benzinga
Phase 3 Trial
Health Care
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.